Monte Rosa Therapeutics Announces Pricing of Initial Public Offering
June 23, 2021 20:20 ET
|
Monte Rosa Therapeutics, Inc.
BOSTON, June 23, 2021 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology company developing a portfolio of novel small molecule precision medicines that employ the...